1. Home
  2. OFIX vs CTMX Comparison

OFIX vs CTMX Comparison

Compare OFIX & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

HOLD

Current Price

$15.51

Market Cap

622.1M

Sector

Health Care

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.16

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFIX
CTMX
Founded
1987
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
622.1M
596.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
OFIX
CTMX
Price
$15.51
$4.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$21.50
$6.50
AVG Volume (30 Days)
218.5K
2.1M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$818,058,000.00
$113,631,000.00
Revenue This Year
$3.97
N/A
Revenue Next Year
$5.84
N/A
P/E Ratio
N/A
$17.49
Revenue Growth
4.31
N/A
52 Week Low
$10.24
$0.40
52 Week High
$20.48
$4.62

Technical Indicators

Market Signals
Indicator
OFIX
CTMX
Relative Strength Index (RSI) 50.21 57.36
Support Level $15.51 $3.78
Resistance Level $16.04 $4.20
Average True Range (ATR) 0.49 0.24
MACD -0.02 -0.02
Stochastic Oscillator 44.41 73.88

Price Performance

Historical Comparison
OFIX
CTMX

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: